Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1986-8-21
|
pubmed:abstractText |
Prostaglandin E2 (PGE2), thromboxane B2 (TXB2; as a stable metabolite of TXA2), prostaglandin F2 alpha (PGF2 alpha) and 6-keto-PGF1 alpha (as a stable end product of prostacyclin) have been measured by using specific radioimmunoassay in the plasma of the cord artery immediately after delivery before the cord was clamped. Plasma prostanoid concentrations in normal deliveries (n = 8, as controls) were 24.8 +/- 2.6 (PGE2), 246.8 +/- 37.0 (TXB2), 122.2 +/- 13.3 (PGF2 alpha) and 82.1 +/- 7.7 (6-keto-PGF1 alpha) respectively (pg/ml, mean +/- s.e). On the other hand, in fetal distressed deliveries showing continuous bradycardia (n = 6), they increased significantly to 275.4 +/- 20.1 (PGE2), 948.6 +/- 102.5 (TXB2), 218.0 +/- 21.4 (PGF2 alpha) and 1498.6 +/- 298.4 (6-keto-PGF1 alpha) respectively (pg/ml, mean +/- s.e, p less than 0.005). However, both PGF2 alpha/PGE2 and TXB2/6-keto-PGF1 alpha ratios declined significantly from 4.70 +/- 0.33 to 0.68 +/- 0.05 and from 3.07 +/- 0.37 to 0.68 +/- 0.12 respectively (mean +/- s.e, p less than 0.005) in the fetal distressed group compared with those of the controls. From these results, it may be concluded that the cord artery, which is known as the patent source for the production of PGE2 and prostacyclin, did exert a sufficiently strong reaction to overcome the undesirable haemodynamic changes to maintain the fetal well-being in utero.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/6-Ketoprostaglandin F1 alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprost,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins E,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins F,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane B2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0013-7219
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3459649-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:3459649-Dinoprost,
pubmed-meshheading:3459649-Dinoprostone,
pubmed-meshheading:3459649-Female,
pubmed-meshheading:3459649-Fetal Blood,
pubmed-meshheading:3459649-Fetal Distress,
pubmed-meshheading:3459649-Humans,
pubmed-meshheading:3459649-Infant, Newborn,
pubmed-meshheading:3459649-Pregnancy,
pubmed-meshheading:3459649-Prostaglandins,
pubmed-meshheading:3459649-Prostaglandins E,
pubmed-meshheading:3459649-Prostaglandins F,
pubmed-meshheading:3459649-Radioimmunoassay,
pubmed-meshheading:3459649-Reference Values,
pubmed-meshheading:3459649-Thromboxane B2
|
pubmed:year |
1986
|
pubmed:articleTitle |
Comparison of plasma prostanoid levels in the human cord artery in normal and fetal distressed deliveries.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|